Monitoring approach: Establish clear metrics (visual field, OCT, visual acuity), measure every 3-6 months, continue peptides if stable or improving, consider break if stable 12+ months on treatment, resume immediately if decline detected during break, accept ongoing use if clearly beneficial and well-tolerated
Dose escalation without clear non-response is guesswork, not pharmacology
Get In Touch Have questions about Glutathione products or research-use details
Cell viability was expressed as percentage of fluorescence intensity relative to untreated controls
One day while healing, she accidentally screamed and her voice took on a raspy quality
SS-31 (Elamipretide) SS-31 is a mitochondrial-targeting peptide that binds to cardiolipin , a key lipid in mitochondrial membranes